Staphylococcal Infections

Search with Google Search with Bing
Information
Disease name
Staphylococcal Infections
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02492958 Completed Phase 2 SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults June 2015 September 2016
NCT00066989 Completed Phase 2 Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates July 2003 August 2004
NCT00071214 Completed Phase 3 Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis September 2003 September 2005
NCT00108160 Completed Phase 4 Preventing Staphylococcal (Staph) Infection April 2005 August 2012
NCT00113191 Completed N/A Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants May 2004 June 2006
NCT01447407 Completed Phase 1 Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine September 2011 December 2012
NCT01643941 Completed Phase 1 Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years August 2012 March 2014
NCT02364596 Completed Phase 1 Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years January 2015 February 2015
NCT00063089 Completed Phase 1/Phase 2 Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever September 2002 September 2004
NCT02502474 Completed N/A Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne February 2, 2015 October 20, 2017
NCT02557568 Completed N/A Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne October 2011 February 2013
NCT02595112 Completed N/A Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery February 4, 2016 September 5, 2017
NCT02640937 Completed Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections November 2011 November 2015
NCT02782078 Completed N/A Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections March 6, 2017 January 3, 2019
NCT02971657 Completed Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients' Clinical Outcome in Orthopedic Device Related Bone Infections November 2011 March 2015
NCT03915470 Completed Phase 2 Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection August 29, 2019 March 29, 2021
NCT04409392 Completed Staphylococcus Lugdunensis Prosthetic Joint Infection February 1, 2021 April 1, 2021
NCT00156377 Completed Phase 4 Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections November 2002
NCT00175370 Completed N/A Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus September 2000 December 2007
NCT00211900 Completed Phase 3 Evaluation of Manufacturing Lot of StaphVAX March 2005 November 2005
NCT00211913 Completed Phase 3 StaphVAX in Cardiovascular Surgery Patients June 2004 January 2006
NCT00211926 Completed Phase 3 StaphVAX Immunogenicity in Orthopedic Implant Patients December 2004 October 2006
NCT00211965 Completed Phase 3 StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery April 2005 August 2006
NCT00211991 Completed Phase 3 Evaluation of Consistency of StaphVAX Manufacturing Lots April 2005 July 2005
NCT00217841 Completed Phase 3 Aurograb and Vancomycin in MRSA Infection January 2004 March 2006
NCT00303069 Completed Phase 1 V710 First-In-Man (FIM) Study (V710-001) November 2005 July 2006
NCT00419991 Completed Phase 4 Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection January 2007 May 2008
NCT00427076 Completed Phase 3 Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections June 2007 June 2014
NCT00501150 Completed N/A Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections September 2005 June 2007
NCT00620984 Completed Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis August 2006 December 2009
NCT00631566 Completed N/A Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons May 2007 October 2017
NCT00666276 Completed Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan) February 2007 April 2011
NCT00736554 Completed What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? July 2008 November 2008
NCT00779246 Completed N/A Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections June 2008 July 2009
NCT00859677 Completed Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection March 2009 August 26, 2016
NCT01018641 Completed Phase 1 An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults January 2010 July 2011
NCT01273922 Completed Phase 1 Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida January 2011 December 2011
NCT01324440 Completed Phase 1 Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) September 2006 October 2007
NCT01364571 Completed Phase 1 Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years August 2011 January 2013
NCT01431326 Completed Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care November 2011 November 2019
NCT05899140 Not yet recruiting Phase 4 Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial February 1, 2024 July 31, 2024
NCT02664740 Not yet recruiting Phase 1/Phase 2 Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus June 1, 2022 August 2024
NCT00130260 Terminated Phase 3 Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease August 2005 April 2006
NCT01196169 Terminated Phase 4 Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty October 2010 March 2014
NCT04141787 Unknown status Phase 4 Ceftriaxone as Home IV for Staph Infections July 11, 2019 March 30, 2024
NCT00518076 Unknown status Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant September 2006
NCT03456544 Unknown status Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China October 31, 2018 December 31, 2019
NCT01144000 Unknown status Phase 2 Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection June 2012 June 2016
NCT00646919 Unknown status Preoperative Nasal Swabs From Pediatric Patients
NCT00423982 Unknown status Phase 4 Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty April 2006 December 2014
NCT00368498 Unknown status Phase 4 A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely June 2006 December 2007
NCT00509847 Withdrawn Phase 1/Phase 2 A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis February 2009 October 2009
MeSH unique ID (MeSH (Medical Subject Headings))
D013203